“For over a decade — and as recently as August — FDA has fully evaluated the emerging scientific evidence and repeatedly ...

Billionaire activist investor Jeff Smith remains bullish on Kenvue (KVUE) despite the stock plunging roughly 28% year-to-date ...

If you’re eyeing Kenvue stock and asking yourself what to do next, you’re definitely not alone. There has been more than a ...

Kenvue Inc. (NYSE: KVUE), spun out from Johnson & Johnson in 2023, is at a crossroads. As the world's largest pure-play ...

(Reuters) -Kenvue has urged U.S. regulators to reject a request seeking autism warning label on its popular over-the-counter ...

After popular pain med Tylenol came under fire from officials in the Trump administration for an alleged link to autism if ...

A potential legal headache for consumer healthcare giant Kenvue ( KVUE 8.36%) was causing pain for investors on Thursday.

Explore Kenvue Inc. (NYSE:KVUE) trends, dividends, and market activity among consumer stocks in S&P 500 today.

On Oct. 17, Kenvue filed a response to the Citizen Petition, arguing against the need to add a pregnancy/autism risk warning ...

Kenvue opposes a Citizen Petition to change Tylenol's pregnancy warning, citing lack of scientific evidence for claims ...

Kenvue urged U.S. regulators to deny a request warning against Tylenol’s use during pregnancy, laying out the most detailed ...

Kenvue, Tylenol manufacturer, has asked US regulators to reject a request for an autism warning label on Tylenol when used ...